D Deykin. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Blood Coagulation Disorders/drug therapyBlood Coagulation Disorders/prevention & controlBlood Coagulation TestsHeparin/administration & dosageHeparin/adverse effectsHeparin/therapeutic useHumansInfusions, ParenteralInjections, SubcutaneousProtamines/therapeutic usePulmonary Embolism/drug therapyThrombophlebitis/drug therapyThrombosis/prevention & control
Substances: See more » ProtaminesHeparin
Year: 1969 PMID: 5775632 DOI: 10.1056/NEJM196904242801706
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245